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Several investigators have demonstrated an increased resistance to the protozoal parasite
Trypanosoma cruzi (the causative agent of Chagas' disease) in highly susceptible C3H mice
when maintained at an environmental temperature of 36°C. This increased resistance is
manifested as delay in onset of parasitemia, decreased parasitemia, decreased pathology, and
increased longevity with eventual clearing of the parasite from the bloodstream. In addition, this
enhanced resistance has been shown to be an immunologic phenomenon and not due to the direct
effects of elevated temperature on the parasite itself. To ascertain the possible contributions of
humoral vs. cellular immunity to the above phenomenon, the relative success of passive transfer
of sera and adoptive transfer of whole spleen cells was evaluated. Parasitemias and mortality of
donor mice maintained at 21°C or 36°C were monitored. The same parameters were monitored
in infected recipient mice held at 21°C and either given sera or whole spleen cells, from the
donors, in an attempt to transfer protective immunity. The results of this experiment indicate
that 1) an environmental temperature of 36°C does reduce the course of infection with T. cruzi,
2) the positive effects of elevated temperature can be transferred to naive mice through the
administration of whole spleen cells from surviving mice, 3) the beneficial effects are magnified
as demonstrated by negligible parasitemias and more rapid clearing of blood-form
trypomastigotes in the recipients of whole spleen cells as compared with the original mice that
survived infection at 36°C, and 4) the positive effects cannot be attributed to antibodies due to
the failure of passive transfer to impart any protection beyond that noted in the controls.

vi

Introduction

Trypanosoma cruzi, the etiologic agent of American trypanosomiasis or Chagas' disease, is
estimated to currently infect up to 18-20 million people in Latin America (W.H.O., 1991) with
one fourth of the total population (90 million more individuals) at risk (W.H.O., 1994).
Mortality resulting from T. cruzi infection is usually a consequence of chronic disease pathology
involving the heart. "Chagas' disease is thought to be the single most common cause of
congestive heart failure and sudden death in the world and the leading cause of death among
young to middle age adults in endemic areas of Latin America" (Tarleton et al., 1997). T. cruzi
is believed to have successfully parasitized the inhabitants of this region since antiquity. Recent
molecular techniques have allowed researchers to positively identify the presence of T. cruzi in
seven approximately 4000 year old mummies unearthed from the Atacama Desert of Peru
(Fackelmann, 1997). The success of the parasite appears to be centered on the availability of a
large range of invertebrate hosts residing in Latin America, coupled with an intermittent indolent
stage of infection that can last for decades in the vertebrate host.
Despite its medical importance, many aspects of T. cruzi infection have continued to evade
investigators. Today it is still not agreed upon as to how this agent causes disease or how the
parasite is able to avoid immune destruction. Because of it's elusiveness, preventative measures,
diagnosis, and effective treatments are far less than adequate. A complete understanding of this
parasite is most likely decades away.

Taxonomy and morphology of the parasite
Trypanosoma cruzi is a member of the Kingdom Protista, Phylum Sarcomastigophora,
Subphylum Mastigophora, Order Kinetoplastida, Family Trypanosomatidea (Brener, 1992). It is
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closely related to other flagellated protists such as Leishmania, Giardia, and Trichomonas.

T.

cruzi does not exist as a homogeneous population but rather as a numerous range of strains that
cycle between domestic and sylvatic hosts including humans, insect vectors, and mammalian
reservoirs of the parasite (Brener, 1992). It is thought that these different strains are capable of
producing varying disease states, with differences in parasitemia levels, virulence, pathogenicity,
sensitivity to drugs, and tissue trophisms (Brener, 1992). Thus the typing or grouping of T. cruzi
strains has been the focus of extensive investigations. "The antigenic make-up of different
populations has been studied by analysis of radio-iodinated cell surface membrane components
and band distribution in SDS-Page gel electrophoresis as well as monoclonal antibodies"
(Brener, 1992). Some strain-specific antigens have been detected, but a great deal of cross
reactivity has been observed (Brener, 1992). Newer approaches to strain characterization are
currently being performed at the molecular level, and surface membrane carbohydrate residues,
specific lectins, and isoenzyme markers are being employed for taxonomic purposes (Brener,
1992).
The structure that seems to hold the most promise for both identification and detection of all
strains of T. cruzi in stained blood samples is the kinetoplast. The kinetoplast represents a
portion of the single complex mitochondrion of the cell and contains a huge compact mass of
DNA arranged into maxicircles and minicircles (Brener, 1992). The kinetoplast-DNA contains
approximately 20 to 25% of the total parasitic DNA (Brener, 1992). The maxicircles are thought
to code for enzymes essential to the metabolism of the parasite (Brener, 1992). The exact
function of the minicircles is still uncertain, but they have been shown to contain highly
conserved sequences in all T. cruzi species (Brener, 1992). Probes specific for these conserved
regions have been useful for detection (Brener, 1992). The minicircles also contain highly
strain-specific variable regions, and specific probes may be useful for more precise identification
(Brener, 1992). The kinetoplast also may serve as a future target for innovative
chemotherapeutic approaches due to the observations that dyskinetoplastic forms of T. cruzi are
unable to complete a normal life cycle (Brener, 1992). Naturally occurring "dyskinetoplastic"
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stages have been identified in Trypanosoma equiperdium and evansi species; however, evidence
thus far indicates that T. cruzi is kinetoplastic-DNA (k-DNA) dependent (Brener, 1992).
T. cruzi possesses a single flagellum arising from a specialized invagination known as the
flagellar pocket at the basal surface of the organism (Brener, 1992). The flagellar pocket is the
apparent site of nutrient uptake from the external media via the process of pinocytosis (Brener,
1992). " The cytosome, an invagination of the surface membrane, is another region in which
incorporation of pinocytotic vesicles and larger particles occurs" (Brener, 1992). The structural
integrity of the parasite is maintained by subpellicular microtubules which act as a cytoskeleton
but also are involved in cellular differentiation and tissue migration within the vertebrate host
(Brener, 1992). The above listed organelles appear to be trypanosomatid-specific. Other
organelles that are present are typical eukaryotic structures such as endoplasmic reticulum,
ribosomes, golgi complexes, and peroxisomes (Brener, 1992). Interestingly, the activity of
enzymes such as catalase and oxidases within the peroxisome is much lower in T. cruzi than in
other similar organisms (Brener, 1992).

Life cycle
T. cruzi exhibits three known life forms. The amastigote form is the spherical intracellular
form, 1.5 to 4.0 (am in diameter, and is usually observed in clusters in infected mammalian cells
(Wendel and Gonzaga, 1993). This form has been reported to have a very short flagellum
(Burleigh and Andrews, 1995). Epimastigotes have a well developed flagellum and a
juxtanuclear kinetoplast and are the form seen in the foregut of the invertebrate vector (Wendel
and Gonzaga, 1993). The trypomastigote stage is usually C or U shaped and approximately 12 to
20 Jim in diameter (Wendel and Gonzaga, 1993). Trypomastigotes are found in the blood stream
and occasionally in the cerebral spinal fluid (CSF) or lymphatic fluid of the vertebrate host
during the acute phase of infection (Wendel and Gonzaga, 1993). At the ultrastructure level,
trypomastigotes have a surface coat three times thicker than epimastigotes with fewer
intramembrane particles and differing plasma membrane characteristics (Burleigh and Andrews,
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1995). Within the host, T. cruzi is an obligate intracellular pathogen because it must enter host
cells in order to replicate (Burleigh and Andrews, 1995).
The infective stage of T cruzi, the metacyclic trypomastigote, develops in the hindgut of the
intermediate host, hematophagus insects belonging to the family Reduvidae (Wendel and
Gonzaga, 1993). Due to development within the hindgut rather than the salivary glands of the
insect vector, the parasite is classified as stercorarian (Bogitsh and Cheng, 1990). This mode of
transmission involves fecal contamination into a bite wound or across mucous membranes or
conjunctiva (Kirchhoff, 1993). However, transmission is easily achieved due to the existence of
many species of Reduviid bugs that defecate immediately following the ingestion of a blood
meal, thus placing feces containing infective forms near the feeding port (Bogitsh and Cheng,
1990). Children have a tendency to rub their face and eyes when first awakening which also
facilitates the transmission of the parasite (Bogitsh and Cheng, 1990). Reservoir hosts (all
mammals) may become infected via ingestion of the infected bugs directly or by the ingestion of
other infected reservoirs (Bogitsh and Cheng, 1990). Once the metacyclic trypomastigote stages
have gained entrance into the mammalian host, local inflammatory cells such as macrophages
and neutrophils attempt to internalize it (Bogitsh and Cheng, 1990). Undetected, the amastigote
forms multiply via longitudinal binary fission (Bogitsh and Cheng, 1990). Transformation
occurs again into the trypomastigote forms which are hematogenously dispersed throughout the
entire body, and new distant cells are subject to becoming parasitized (Kirchhoff, 1993). " In
this way, a cycle is established that alternates asynchronously between intracellular multiplying
forms and nondividing but infective forms that circulate in the bloodstream" (Kirchhoff, 1993).
Completion of the cycle occurs when the reduviid bug takes a blood meal from an infected
host and ingests the infective trypomastigote form (Kirchhoff, 1993). Once the parasite reaches
the foregut of the insect, transformation occurs into the reproductive epimastigote stage and
division occurs again via binary fission (Bogitsh and Cheng, 1990). Ten days after ingestion,
infective metacyclic trypomastigotes can be identified in the rectum of reduviid bugs (Bogitsh
and Cheng, 1990).
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Vector
Invertebrate hematophagus bugs belonging to the Family Reduvidae, Subfamily Triatominae,
are responsible for transmission of T. cruzi (Wendel and Gonzaga, 1993). These insects are
commonly called kissing bugs (Bogitsh and Cheng, 1990). Over ninety species exist worldwide
of which forty have adapted to human habitats and thirty are linked with Chagas' disease
transmission (Wendel and Gonzaga, 1993). The insects are widely distributed geographically on
the American continents from Utah to Argentina with a predominance of certain species in
specific geographical zones (Wendel and Gonzaga, 1993).

Modes of transmission
The sylvatic cycle involves reduviid bugs dwelling in holes within the bark of trees, in caves,
or under rocks, where they are in constant contact with numerous natural reservoirs (Wendel and
Gonzaga, 1993). The domestic cycle is very prevalent due to man's encroachment into naturally
endemic areas and the extreme poverty of the inhabitants (Wendel and Gonzaga, 1993). The
typical dwellings, or "ranchos", in the "backlands" of Latin America are rudimentary at best.
The walls, which are constructed of wattle or bamboo filled in with mud, are full of holes and
cracks (Wendel and Gonzaga, 1993). Palm thatches, an ideal habitat for triatomes, are used for
roofing (Wendel and Gonzaga, 1993). These huts are usually windowless (Wendel and Gonzaga,
1993). One structure such as this can harbor hundreds to thousands of reduviid bugs (Wendel
and Gonzaga, 1993). Families co-exist in such dwellings along with cats, dogs, rats, etc.
(Wendel and Gonzaga, 1993). Any domestic animals a family may own are kept very near the
dwelling and thus a reservoir is always at hand. Tiny villages of such dwellings in very poor
areas with little medical care have allowed for the continued presence of the domestic cycle of
T. cruzi for thousands of years.
Although uncommon, transplacental transmission was first described by Chagas in 1909.
Lactogenic transmission may also serve as a secondary route of infection since T. cruzi can be
found in the breast milk of infected women (Wendel and Gonzaga, 1993). Blood transfusion and
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organ donor associated transmission have been reported with the former being the second most
prevalent mode of transmission in endemic areas (Wendel and Gonzaga, 1993).

Pathology
T. cruzi infection usually manifests as a triad of complexes. The first phase of infection is the
acute form that typically develops one to three weeks post infection (Bogitsh and Cheng, 1990).
This stage may be indolent and go unnoticed or it may present with the classic clinical signs of
edema and erythema at the site of parasite entry (Kirchhoff, 1993). These outward signs
correlate with the initial invasion and multiplication of the parasite within macrophages of the
subcutaneous tissues. This swelling is commonly termed a "chagoma" (Bogitsh and Cheng,
1990). If the initial site of entry is the conjunctiva of the eye, then a syndrome involving
periorbital edema and conjunctivitis ensues, which is termed "Romana's sign" (Bogitsh and
Cheng, 1990). During the acute phase the number of circulating blood-form trypomastigotes is
at its highest. This stage is often accompanied by fever, headache, malaise, generalized
lymphadenopathy, and hepatosplenomegaly (Kirchhoff, 1993). Acute trypanosomiasis is usually
a mild illness with a case fatality rate of less than 5% (Kirchhoff, 1993). The fatalities are most
numerous in very young children and are due either to the invasion of T. cruzi into myocardial
cells causing severe myocarditis or into the central nervous system leading to
meningoencephalitis (Kirchhoff, 1993). "The factors that determine the severity of the disease in
the acute phase are uncertain, but likely to be involved are the virulence of different strains of T.
cruzi, the general state of health of the individual, and possibly his genetic background"
(Trischmann et al., 1978). Those that survive the acute illness will experience spontaneous
resolution over the next four to six weeks, and a quiescent infection ensues for an undetermined
length of time (Kirchhoff, 1993). Victims are either asymptomatic or suffer mild intermediate
bouts similar to those seen with the acute infection and may experience subtle cardiac or
gastrointestinal involvement (Kirchhoff, 1993). At these times of reactivation, low parasitemias
often can be detected (Kirchhoff, 1993). This cycle enhances the domestic transmission of T.
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cruzi as humans can act as a reservoir, thus producing the threat of transfusion and organ donor
transmission. Many individuals remain in this indeterminate phase for life (Kirchhoff, 1993).
Within this phase an immunity appears to be present that prevents subsequent re-infection by the
same strain of T. cruzi, but does not always prevent the chronic phase from developing
(Trischmann et al., 1978). An estimated 10 to 30% of infected people will develop chronic
Chagas' disease years to decades after initial infection (Kirchhoff, 1993). Organs most
commonly affected include the heart, the esophagus, and the colon (Kirchhoff, 1993). The
damage to the esophagus and colon may result in a syndrome known as megadisease (Kirchhoff,
1993). The pathology of megadisease is primarily associated with the loss of local denervation
leading to flaccid paralysis of these very distendable organs. Clinical manifestations include
dysphagia, regurgitation, aspiration, and severe constipation (Kirchhoff, 1993). The heart has
the gross appearance of congestive heart failure with biventricular enlargement and consequent
wall thinning (Kirchhoff, 1993). The situation is very conducive to the formation of aneurysms
(Kirchhoff, 1993). Histologically, there is diffuse interstitial fibrosis and myocardial atrophy
(Kirchhoff, 1993). Clinical signs are indistinguishable from chronic heart failure (Kirchhoff,
1993). Thus Chagas' disease can develop silently and become incurable.

Chronic Chagasic pathology
"A number of mechanisms have been proposed to account for chronic Chagasic pathology
including direct parasite-mediated tissue destruction, loss of nervous tissue function,
intravascular platelet aggregation, and generation of an autoimmune reactivity" (Tarleton et al.,
1997). The presence of an anti-self immune response has been unquestionably demonstrated, but
its role in disease development is still undetermined (Tarleton et al., 1997). Supporting evidence
for an underlying autoimmune etiology is the observation of the scarcity of parasites in the
chronically inflamed tissues and the existence of shared epitopes between the parasite and host
heart and neuronal tissue (Reviewed in Tarleton et al., 1997).

8

Investigations performed by Ribeiro-dos-Santos et al. (1992) strongly supported an
autoimmune basis for the observed pathology. In these experiments, mice that were chronically
infected with T. cruzi vigorously rejected normal uninfected heterotopic neonatal heart
transplants in comparison to normal mice receiving the same treatment. These results suggested
that chronic status had induced some type of anti-heart response. Further investigation led to the
conclusion that the major effector cell in this response was the CD4+ T cell, since depletion of
this subset prevented the rejection phenomenon.
More recently (1997) Tarleton et al. repeated these experiments and obtained very different
results. With lower parasite burdens the heart tissue was not rejected even after eight months.
Using kinetoplastic DNA polymerase chain reactions (kDNA PCR) no T. cruzi forms were
located in the tissue post transplantation. The authors maintained that the failure of the
transplanted tissue to become parasitized demonstrates the efficacy of the immune response in
controlling the spread of parasites to other sites of the body (Tarleton et al., 1997). This
hypothesis supports previous observations of low levels of detectable circulating parasites in
chronically infected hosts (Reviewed in Tarleton et al., 1997), as well as previous studies
documenting the restriction of tissue parasites to the heart and skeletal muscle in C3H mice
chronically infected with the SylvioX/10 clone of T. cruzi (Reviewed in Tarleton et al., 1997).
When Tarleton and co-workers subjected the native hearts of chronically infected mice to kDNA
PCR, they detected parasites in close association with inflammatory infiltrates. This finding
provided evidence of an inflammatory process as the etiology for chronic Chagas' disease. This
hypothesis is supported by a growing body of evidence connecting disease severity with the
virulence of the infecting parasite strain, the persistence of parasites in the diseased tissues, and
the efficacy of anti-parasite chemotherapy {Reviewed in Tarleton et al., 1997). In addition, Arif
(1996) demonstrated that the lower numbers of circulating parasites observed in mice maintained
at 36°C is correlated with lower levels of tissue parasitism, inflammation and tissue destruction.
Immunity in T. cruzi infection
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Infection with T. cruzi is accompanied by the down regulation of immune responses
(Tarleton, 1991). The specific mechanisms that account for this suppression are not agreed
upon, and likewise, neither is the significance of this phenomenon to the course of acute and
chronic infection (Tarleton, 1991). It is believed that the immune system, although quite
suppressed, is adequate to control the acute infection in most hosts (Tarleton, 1991). The onset
of this immune response is correlated with the progression from the high parasitemias of the
acute phase to virtually undetectable parasitemias in the chronic phase (Tarleton et al., 1996).
There also exists strong evidence that the immunosuppressive response seen in chronic Chagas'
disease is a contributing factor to disease development (Tarleton, 1991).
IL-2 production has been shown to be severely depressed during the acute phase of T. cruzi
infection (Harel-Bellan et al., 1983; Tarleton and Kuhn, 1984). The cellular and molecular
mechanisms of this suppression are not yet clear (Tarleton, 1991). IL-2, known to play an
important role as a T cell growth factor, has been shown to be influenced by C D 8 + T cells in
vitro and in vivo (Tarleton, 1991). Exogenous IL-2 administration can alter the immune
responsiveness of lymphocytes from T. cruzi infected mice as well as the course of infection, but
cannot completely overcome immunosuppression or result in a parasitological cure (Tarleton and
Kuhn, 1984; Choromanski and Kuhn, 1985; 1987).
T. cruzi infected mice have normal to elevated levels of IFN-y (Nabors and Tarleton, 1991).
Serum levels are detectable until day 18-20 post infection at which time a significant drop is
noted (Tarleton, 1991). This drop also corresponds to a decrease in IL-2 production (Tarleton,
1991). IL-2 treatment of spleen cells from infected mice has been shown to increase IFN-y
production, suggesting that IFN-y production is mediated by IL-2 (Tarleton, 1991). IFN-y has
been shown to significantly decrease parasite load in vitro and in vivo (Reed et al., 1987; Wirth
et al., 1985). However, the endogenous production seems to be insufficient to mediate resistance
in vivo (Tarleton, 1991). Both IL-2 and IFN-y are secreted by the T helper subset TH1
(Mosmann et al., 1986; Street and Mosmann, 1991). It has been suggested that there is either a
selective suppression of TH1 cells for IL-2 production but not IFN-y production or that there is
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complete suppression of TH1 cells and an alternative source of IFN-y such as varying T cell
subsets or natural killer cells (Tarleton, 1991). These cell types have been reported to secrete
IFN-y but only in in vivo antibody depletion studies. Nabors and Tarleton (1991) demonstrated
that TH1 cells are the major producers of IFN-y in the spleens of T. cruzi infected mice, thus
implicating a negligible role for other cell types. The TH2 cell subset, which secretes other
cytokines such as IL-5, IL-6, and IL-10, is not necessarily suppressed nor markedly stimulated
by T. cruzi infection (Tarleton, 1991).
Because T. cruzi gains entrance into a wide variety of host cells, it was long thought to
occupy a protective niche from immune destruction (Tarleton, 1990). While infected
macrophages that have engulfed the organism are able to destroy it, the intracellular destruction
of T. cruzi in other host cells such as smooth and cardiac muscles, neurons, and fibroblasts has
not been widely reported (Tarleton, 1990). However, it has been shown that CD8 + cytotoxic T
cells play a major role in the destruction of parasitized mammalian cells. The in vivo depletion
of C D 8 + T cells by anti-CD8 monoclonal antibody increased the susceptibility of both resistant
and highly susceptible mouse strains to T. cruzi infection resulting in increased parasitemia and
increased mortality (Tarleton, 1990; 1991). The crucial role that C D 8 + T cells play in the
immunity against T. cruzi was supported by another study that reported the failure of P2microglobulin-deficient mice which lack class I MHC molecules, to resist this parasitic infection
(Tarleton, 1992). In addition, Ming (1994) and Guo (1994) demonstrated that the protective
effect of elevated environmental temperature during experimental Chagas' disease is lost when
mice are depleted o f C D 8 + T cells or C D 4 + T cells in vitro. Lytic antibodies may play a role in
the lysis of extracellular trypomastigote forms, facilitate parasite uptake by phagocytic cells, and
aid in antibody dependent cellular cytotoxicity (Reviewed in Tarleton, 1990).

Therapeutic effects of fever and hyperthermia
Rufus of Ephesus stated, "I think that you cannot find another drug which heats in a more
penetrating manner than fever...and if there were a physician skillful enough to produce a fever,
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it would be useless to seek any other remedy against disease" (Atkins, 1984). A fever or febrile
response occurs in almost all infectious processes (Wan and Blackburn, 1992). Fever is defined
as a physiological rise in core body temperature due to either an increase in the set point around
which body temperature is normally centered, or a decrease in the thermal sensitivity of central
heat sensitive neurons (Wan and Blackburn, 1992). A fever is characterized by a rise in core
body temperature of approximately 2°C to 3°C above normal (Hansen, 1993).
As early as the turn of the century, observations were being made concerning seasonal
variations in the clinical manifestations of several infectious diseases including St. Louis
encephalitis virus, rickettsial typhus, and diphtheria toxin in laboratory animals (Kolodny, 1939).
Since the above mentioned diseases are caused by very different etiologic agents (a virus, a
rickettsia, and a bacterium) it was hypothesized that these seasonal changes must be due to
changes in the efficacy of the normal defense mechanisms of the hosts (Kolodny, 1939).
The role that elevated temperature plays in overcoming pathogens has been widely
recognized and studied. In 1927, Julius Wagner-Jauregg, an Austrian psychiatrist, was awarded
the Nobel Prize in Physiology and Medicine for his work in developing a therapy for syphilisrelated paralysis that involved transfusing blood from patients infected with malaria to those
suffering from syphilis in hopes that the high fever created by the malarial infection would
reduce the syphilitic paralysis (Stine, 1992).
Increases of temperature similar to a natural febrile response have been linked to decreased
lesion scores, decreased fecal scores, and increased hematocrits in broiler chicks infected with
Eimeria tenella (coccidiosis) (Anderson et al., 1976). Miyamoto et al. (1995) demonstrated that
guinea pigs developed a graded fever response depending on the injected dose of Legionella
pneumophila.

Sublethal infections of L. pneumophila

produced a lesser and more gradual febrile

response that peaked at day three and returned to normal by day seven. The fever of lethally
infected animals peaked at day one with a higher response and stayed high until day four. All
guinea pigs given a lethal infection expired by day six.
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Almost all bacteria that are pathogenic for humans are mesophilic (Mackowiak, 1981). Of
these, many are very labile at temperatures > 41°C such as Streptococcus pneumonia and
Niesseria gonorrhea (Mackowiak, 1981). Other bacteria such as Escherichia coli seem to be
heat stable even at the upper limits of the febrile response (Mackowiak, 1981). For those species
that are temperature sensitive, the effect seems to be directly upon the bacteria. At increased
temperatures, decreased growth rates, synchronized cell division, changes in morphologies,
decreased motility, and damage to cell walls leave the bacteria very vulnerable to damage
(Mackowiak, 1981). Many instances of improved clinical outcome have been documented in
association with an elevated body temperature of 40°C (Mackowiak, 1981). For example,
elevated body temperature is restrictive to the growth of Haemophilis influenzae in the cerebral
spinal fluid of rabbits (O'Reilly and Zac, 1992). An increased survival is also noted in rabbits
when a fever is mounted to Pasteurella multocida infection (Kluger and Vaughn, 1978).
Retrospective studies on meningetic patients showed that mortality is significantly lower in
patients with fever than in patients without fever or with hypothermia (O'Reilly and Zac, 1992).
Elevated body temperature also has been correlated with improved outcome in spontaneous
bacterial peritonitis (Weinstein et al., 1978), gonorrhea, and neurosyphilis (Rodbard, 1981).
Whole body hyperthermia (WBH) has been shown to have intrinsic cytoreductive potential
and to lead to dramatic but short term remission in a number of malignancies (Robins et al.,
1989). This phenomenon may be partially accounted for by the extreme heat sensitivity of cells
actively undergoing mitosis. The aggregation of globular proteins in the spindle apparatus or the
disaggregation of spindles renders the cells unable to complete the mitotic division (Overgaard,
1977). WBH also has been used as an adjunct to radiation and chemotherapy (Robins et al.,
1989). Analysis from several experiments performed by Robins and co-workers suggests that
WBH may impart myeloprotection at this critical time of white blood cell nidar. These
investigators showed that there were increases in the G-colony stimulating factors IL-lb and IL6, both of which are cytokines that may play a role in stimulating myeloid, erythroid, and
megakaryocyte progenitor cells, and thus may increase platelet, red blood cell, and white blood
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cell counts in patients. Recently, hyperthermia has been used in the multi-model treatment for
HIV and is hypothesized to decrease the number of mutant HIV strains arising early in the
disease process (Owens and Gasper, 1995). Hyperthermia also has shown unexpected success in
the treatment of Kaposi's sarcoma (Steinhart et al., 1996; Logan and Alonso, 1991; Alonso et al.,
1992).
Although the positive effects of an elevated temperature on various disease states have been
well established, no one has been able to explain the mechanism(s) that accounts for this
phenomenon. It seems that in every experiment a different mediator is implicated. The reason
for the disparity is most likely due to fever being a multifactorial process.
T cells have been shown to be a major player in the enhanced immune response seen in
febrile conditions. The increased immunity involves T cell proliferation (Gern et al., 1991), T
cell dependent humoral responses, T cell secretion of interleukin-2, and T cell-mediated
macrophage activation (Jampel et al., 1983).
An elevated in vitro temperature of 40°C has been shown to have profound effects upon
murine macrophage function including increases in cytotoxic activity, phagocytosis, Fc receptor
expression, spreading, and oxidative burst (Van Bruggen et al., 1991). Elevated temperatures
also have been shown to amplify the induction of nitric oxide (NO) synthesis (Bernard et al.,
1994). NO's appear to provide a protective mechanism against intracellular parasitism in rodents
(Green etal., 1991).
Another factor that may contribute to the protection observed in an elevated temperature
response is heat shock proteins (HSPs). HSPs are produced by cells in response to certain
stresses (Dimock et al., 1992). They play a very important role in the ability of cells to
withstand high temperatures (Welch, 1992), exposure to the cytotoxic effects of tumor necrosis
factor alpha and beta (Jaattela et al., 1989) and IL-1 (Margulis et al., 1991), oxidative injury
(Healy et al., 1992), and to the lethal effects of bacterial endotoxins (Ryan et al., 1992; Hotchkiss
et al., 1993). Heat shock proteins on the parasite can serve as targets of the immune response and
parasitic HSPs may be among the most immunogenic of all parasitic antigens (Hedstrom et al.,
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1988; Newport et al., 1988; Engman et al., 1990; Young, 1990). Since HSPs exist on all cells
and a high degree of
sequence homology exists between host HSP and T. cruzi HSP, these have been implicated as a
potential mechanism in auto-immune pathology (Newport et al., 1988; Mattei et al., 1989;
Young, 1990). However, Engman et al. (1990) have down-played this theory by demonstrating
that antibodies to parasite HSP 70, the major target of antibodies in infected persons, were highly
specific for parasite HSP and did not cross react with the homologous human HSP.

The effects of elevated environmental temperature on American trypanosomiasis
Due to the fact that T. cruzi is prevalent in tropical climates and commonly demonstrates a
chronic intermittent pathogenicity in vertebrates, investigators began to question if the
supranormal ambient temperature somehow contributed to the host's ability to survive acute
infection and curtail the course of disease. In 1939, Kolodny showed that mice infected with a
lethal dose of T. cruzi from October until May developed very high parasitemias within 20 days
and had a near 100% mortality rate. In contrast, mice infected in July or August developed
lower parasitemias and exhibited approximately 80% survival. In 1940, Kolodny took this work
further and set up an experiment that kept infected mice at three different environmental
temperatures; (1) room temperature, (2) 40°F-45°F (designated "cold stress"), and (3) 90°F-95°F
(designated "heat stress"). The cold stress group maintained a rectal temperature of less than 1°F
below normal rectal temperature and yet developed parasitemias several times more intense than
any other group. All mice in the cold stress group died. There was a 100% survival rate in the
other two groups with infected mice in the heat stress group displaying much lower parasitemias.
Interestingly, Kolodny noted that the elevated temperature group had an increase in rectal
temperature of 2°F to 3°F. Kolodny concluded that this 2°F to 3°F elevation in body
temperature slightly increased the resistance of the mice to T. cruzi. This resistance was
manifested by lower parasitemia levels and increased survival. However, a less than 1°F lower
body temperature led to a much more intense infection with much higher parasitemia levels and
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fatality. In 1965, Trejos et al. observed that when mice were placed at 18°C vs. 37°C very
specific temperature to parasitemia level ratios were evident. If given a non-lethal infection with
T. cruzi, the mice at 18°C developed much higher parasitemias than those at 37°C. If the mice
originally held at 18°C were then transferred to a 37°C environment, parasitemia levels dropped
dramatically after four days. When the reverse experiment was performed and the mice
originally at 37°C were moved to an 18°C environment, rapid increases in parasitemia levels
were seen. If lethal infections of T. cruzi were given, all mice in the 18°C group died while only
50% of the mice died in the 37°C group. The authors went a step further and tried to determine
if death of mice was due to myocardial effects of the parasite. Histological sections revealed
numerous parasites within the myocardium with subsequent severe myocarditis in all mice in the
18°C group, while there was no evidence of pathology in mice in the 37°C group.
In 1966, a scientist by the name of Marinkelle was completing a five year study of Chagas'
disease in Columbia. At this time he had estimated that approximately two million Colombians
harbored T. cruzi, a large number of whom were apparently healthy carriers. He began to ponder
the significance of this "healthy" carrier state in relation to the warm tropical climate. In 1968,
he and Rodriguez published a paper addressing the influence of environmental temperature on
the pathogenicity of T. cruzi. Their work supported the results of previous studies demonstrating
that there was an inverse correlation between temperature and intensity of disease. Marinkelle
and Rodriguez demonstrated greater than 90% survival in mice held at 36°C up to 180 days post
infection in contrast to 100% mortality in mice held at 25°C by day 15 post infection. The
authors hypothesized that this protection was mediated by some natural immune phenomenon
and that the relative increase in the ambient temperature in many areas where Chagas' disease is
endemic may result in the rapid activation of this response thus protecting many individuals
infected with T. cruzi.
After nearly three decades of research, it was well documented that maintenance of animals at
elevated temperature resulted in lower parasitemias and decreased mortality during infection
with T. cruzi. Such results brought about the obvious question: is the response seen in elevated
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temperature due to an effect on the parasite's ability to cause disease or to the immune system's
ability to combat disease?

Elevated temperature effects on the parasite
Although most research has indicated an immune enhancement due to elevated temperature,
there are several works that describe a direct temperature effect on the parasite itself. The two to
three degree elevation in core body temperature produced by an ambient temperature of 36°C is
not directly lethal to parasites (Otieno, 1973). As stated previously, parasites are very capable of
infecting immunocomprimised hosts maintained at 36°C (Otieno, 1973). However, the increased
temperatures have been shown to result in some physiological changes. In vitro studies have
shown that some strains of T. cruzi are unable to differentiate from the amastigote to the
trypomastigote form at 37°C to 38°C (Bertelli et al., 1977; Neva et al., 1961). In other studies
this result has been contradicted, and an increase in the penetration of cells by trypomastigotes
has been seen at these temperatures (Dvorak and Poore, 1974). The major consequences of a
higher temperature were noted in changes in the time required by the parasite to transverse the
lag period and reproductive phase (Dvorak and Poore, 1974). An increase in environmental
temperature from 29°C to 35°C caused the lag period, i.e., the time interval between the
penetration of the host cell by a trypomastigote and the onset of reproduction by an amastigote,
to decrease linearly (Dvorak and Poore, 1974). This lag period changed from 39.8 hours at 32°C
to 18.4 hours at 38°C (Dvorak and Poore, 1974). Thus it would seem that an elevated
temperature environment actually benefited T. cruzi by enhancing penetration and decreasing the
lag time. However, the doubling time (the time required for reproduction) increased from 12
hours at 32°C to 15.7 hours at 38°C (Dvorak and Poore, 1974). Despite the altered times of
events seen with varying temperatures between 29°C and 36°C, the course of the intracellular
cycle was essentially the same.
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In 1972, Otieno reported that the pathogenicity of various strains of T. cruzi at room
temperature versus elevated temperature was strain specific. In 1973, Otieno also reported that
T. brucei or T. cruzi transformed from a predominately monomorphic long form to a
pleomorphic mixture of long and stumpy forms when mice were maintained at 36°C.

Elevated temperature effects on the host immune response to T. cruzi
In 1967, Amrein demonstrated that the immunosuppressive corticotropic hormone, Decadron,
could reverse the beneficial effects of elevated environmental temperature. Infected mice
maintained at elevated temperature but treated with Decadron showed a 60% mortality rate with
numerous trypanosomes present in the peripheral blood and heart tissue. This result provided
evidence that the temperature effects were an immunological phenomenon rather than due to
direct effects of temperature on the parasite. In these studies, the parasite was very capable of
inducing pathogenesis and mortality and the only change had been in the drug lowering the
immune status of the mice. Following Amrein's studies, several different experiments were
performed using immunosuppressive agents such as cyclophosphamide (Otieno, 1973; Dimock
et al., 1992) and whole body irradiation (Otieno, 1973). The results again showed that
immunosuppressive treatment prior to inoculation with a lethal dose of T. brucei or T. cruzi
reversed the positive effects otherwise noted in an elevated temperature environment. Serologic
analysis of the irradiated mice in Otieno's study failed to demonstrate agglutinating or
precipitating antibodies on the ninth and twelfth day post infection, days in which nonirradiated
mice developed strong responses of this type. This result indicates that the humoral response of
mice was impaired by irradiation.
In 1989, Anderson and Kuhn turned their investigations toward determining the aspects of the
immune response which were important for the development of resistance to T. cruzi at elevated
environmental temperatures. They looked at a broader scope of the elevated temperature effects
to include not only parasitema levels and longevity but also antibody responses and T. cruzispecific helper cell responses to heterologous antigens. To determine exactly how ambient

18

temperature influences body temperature, rectal probes were used to monitor temperature
fluctuations of mice held at room temperature versus 36°C throughout the day. All mice
exhibited similar circadian rhythms with the peak temperatures occurring at approximately 3
A.M. and the low body temperatures occurring in the early afternoon as would be typical for
nocturnal animals. Temperature ranges for mice held at 25°C ranged from 33.7°C to 35.7°C.
Temperatures for those maintained in the 36°C environment ranged from 37.4°C to 38.8°C. This
increase is very similar to that seen in a natural febrile response. The effect of increased
environmental temperature on antibody production to sheep red blood cells (srbc) was measured
on day 25 and 35 of infection and compared with the responses of age matched noninfected
controls (Anderson and Kuhn, 1989). Day 25 was chosen because it is at this time the acute
phase of infection is rapidly progressing when mice are maintained at room temperature. Day 35
represents the time of highest parasitemia just prior to death (Anderson and Kuhn, 1989). Mice
maintained at 36°C showed a significantly greater anti-srbc direct plaque forming cell (DPFC)
response than mice kept at room temperature. The noninfected control mice in both groups
demonstrated a slightly greater response than either of the infected groups, thereby indicating
some degree of suppression of parasite-induced antibody formation. On day 25, the 36° C mice
showed a significantly greater DPFC response than infected mice at room temperature. "On day
35 of infection the DPFC response to srbc from mice held at 36°C was much higher than that of
infected mice held at room temperature and was in fact slightly higher than the DPFC response
of age-matched noninfected controls" (Anderson and Kuhn, 1989). Suppression of parasite
specific T cell responses was measured using T. cruzi conjugated to the hapten trinitrophenyl
(TNP-JC). The DPFC response to TNP-TC from infected mice kept at 36°C was slightly higher
than for those mice kept at room temperature indicating that maintaining mice at an elevated
temperature may abrogate parasite specific suppression of T helper cell responses (Anderson
and Kuhn, 1989).
In 1991, Dimock et al. investigated the production of parasite specific antibodies in protected
mice. Previous studies had indicated an enhanced ability of B cells to produce antibody at
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elevated temperatures both in vitro (Reviewed in Dimock et al., 1991) and in vivo in T. cruziinfected mice (Anderson and Kuhn, 1989). The results of the study performed by Dimock and
co-workers showed that mice held at room temperature developed very high parasitemias, high
levels of antibodies, and had a 100% mortality rate. In contrast, mice held at 36°C displayed low
parasitemia levels, low detectable antibody levels, and had a 100% survival rate. The latter
group did not show a peak in parasitemia until much later than day 35, which is the day of peak
parasitemia in mice held at room temperature. Dimock et al. suggested that antibodies could
play a protective role later in infection at elevated temperature, but this effect was not measured
in their study. The authors also proposed that in the early course of infection, low levels of
antigenic stimulation may inhibit antibody formation and, therefore, some other aspect of the
immune response must be responsible for the observed protection. It was suggested that cellmediated factors such as T helper cell responses which have been shown to be enhanced at the
time of acute infection (Anderson and Kuhn, 1989) and interleukin (IL) activity including IL-1
(Duff and Durum, 1983) or IL-2 (Choromanski and Kuhn, 1985) may be playing a role early in
infection. Dimock and co-workers clearly indicated little role for parasite-specific antibodies in
the resolution of acute infection with T. cruzi. The level of antibody produced did not
correspond with survival but rather showed a linear relationship that correlated with parasite
number. If noninfective culture forms of T. cruzi were injected into mice maintained at 36°C
during the acute phase, heightened antibody production was observed. This result implied that
low antibody levels were due to low parasite number and not vice versa.
In 1992, Dimock et al. performed an experiment designed to measure antibody production in
mice held at elevated temperature throughout the course of infection. A parasite-specific ELISA
was used to measure levels of anti-T. cruzi IgG in the sera of infected mice. In mice maintained
at 36°C, a progressive increase was noted throughout the course of infection. Immunoblot
assays indicated that the reactivity of parasite-specific antibodies increased to a peak at day 91
post infection. Interestingly, parasite levels were almost completely undetectable at this time.
The authors also investigated the nature of surface antigens produced by blood-form
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trypomastigotes (BFTs) held at 36°C versus room temperature. At day 25, BFTs from mice
maintained at 36°C produced a 61 kDa antigen that reacted strongly with sera from mice kept at
this temperature. This response remained strong throughout infection. This same antigen
reacted only weakly with sera taken from mice kept at room temperature and was not recognized
prior to day 25. An antigen of similar molecular weight was produced by BFTs of mice held at
room temperature, but in a much more limited quantity. Mice at both temperatures produced a
19 kDa parasite antigen, however, a more intense reaction was seen with sera from the 36°C
mice. These results suggested either variable antigenic presentation or various immunogenic
properties of antigens at the two temperatures. The results also provided evidence for a strong
antibody response in mice held at 36°C. This response showed a delayed onset and did not
correlate with parasitemia levels.

Passive transfer of immunity
Passive transfer of immunity refers to the injection of preformed antibodies or immune sera
into a naive host. The protection offered by the humoral branch of the immune system is largely
only effective against pathogens free in the serum and not against intracellular entities.
Antibodies play several important roles in pathogen destruction including neutralization,
immobilization, or agglutination (Janeway and Travers, 1996). Thus antibody participates in
direct pathogen inactivation. Antibodies can also perform different rolls such as opsinizing
antigens to facilitate destruction by macrophages or antibody-dependent cell-mediated
cytotoxocity (ADCC) via natural killer cells or other cells which bear Fc receptors for
immunoglobulin (Janeway and Travers, 1996). Antibody can also bind to solubilized antigen,
which is protected from other immune components, and form a complex that readily precipitates
(Janeway and Travers, 1996). Once it is in this state, macrophages or the complement cascade
can destroy it (Janeway and Travers, 1996). In fact, an antigen/antibody complex is required for
the activation of the classical complement cascade (Janeway and Travers, 1996). In addition, B
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cells can act as antigen presenting cells to T cells in much the same way as macrophages, except
they are uniquely adapted to the uptake of soluble antigens (Janeway and Travers, 1996).

Adoptive transfer of immunity
Adoptive transfer refers to transfer of the capacity to make an immune response by the
transplantation of immunocompetent cells (Benjamini and Leskowitz, 1988). The source of
adoptive transfer is commonly attributed to T cell function, and thus is also termed cellular
immunity. However, cellular immunity is multifactorial, and although T cells are the major
players, many other cellular elements may also be involved.
T cells are produced in the bone marrow and mature in the thymus. Once mature, they
circulate in the peripheral lymphoid organs. Naive T cells must be activated by the presentation
of specific antigens on the surface of specialized antigen presenting cells i.e., alveolar, splenic,
and peritoneal macrophages; dendritic cells located in the spleen, lymph node, and skin; Kupffer
cells in the liver; or microglial cells in the CNS (Janeway and Travers, 1996). Antigen
presenting cells which are located along capillary beds make first contact with a nonspecific
invading antigen (Janeway and Travers, 1996). They engulf it, denature the antigen, and place
peptide fragments of the antigen onto surface proteins known as major histocompatability
complex (MHC) proteins (Janeway and Travers, 1996). In this way, an antigen is presented to a
T cell (Janeway and Travers, 1996). The cells possess two different types of cluster of
differentiation molecules, which are surface glycoproteins, termed CD4 and CD8. If a
presenting cell uses a MHC class I molecule to present an antigen it will be recognized by T cells
bearing the CD8 on it's surface (Janeway and Travers, 1996). These are commonly called
cytotoxic T cells and are involved in the direct killing of the target cell (Janeway and Travers,
1996). If the presenting cell uses a MHC class II molecule to present the antigen, it will be
recognized by T cells that have a CD4 glycoprotein (Janeway and Travers, 1996). CD4 bearing
T cells are divided into two groups, TH1 and TH2 cells (Janeway and Travers, 1996). The
activation of either TH1 or TH2 cells is a profound decision and appears to be mediated, at least
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in part, by the cytokines IL-4 and IL-12 (Janeway and Travers, 1996). If TH1 cells are activated
they function to activate infected macrophages to destroy intracellular pathogens (Janeway and
Travers, 1996). This process amplifies cell-mediated immunity (Janeway and Travers, 1996). If
TH2 cells are activated they in turn activate B cells to produce more antibody, and thus amplify
the humoral response (Janeway and Travers, 1996). Helper T cells secrete an array of B cell
activating cytokines (IL-4, IL-5, IL-6, and IL-10) (Janeway and Travers, 1996). Inflammatory T
cells secrete cytokines that activate macrophages such as IL-2, I FN-v, and TNF-/J (Janeway and
Travers, 1996). Cytotoxic T cells also release I F N - j which activates natural killer cells
(Janeway and Travers, 1996).

Previous studies on the transfer of immunity to T. cruzi
In 1979, Guhl and co-workers performed experiments designed to determine if the immunity
acquired at elevated environmental temperature could be transferred to naive recipients. Three
groups of mice were given an inoculant of a lethal dose of the Tulaheun strain of T. cruzi. Group
A mice were maintained at 36°C and served as serum donors for group C. Group B mice were
maintained at 25°C, and mice in Group C were maintained at 25°C plus were given daily
injections of 0.2 ml of serum from Group A. The mean survival in each group was as follows:
Group A-230 days, Group B <13 days, and Group C >350 days. Since the antibodies produced
by the heat-stressed mice were apparently able to passively impart protection, it was concluded
by the authors that the protection was due to increased stimulation of the immune system and not
due to the direct effect of high temperature on the parasite. This conclusion was further
supported by the fact that the parasites that infected Group C had never been exposed to the
increased ambient temperature.
In 1975, Kuhn and Durum tried to determine the kinetics of the immune response against T.
cruzi by injecting recipient mice with spleen cells from donor mice at varying days post
infection. They found no increase in survival until nine days post-infection. From this point the
longevity of recipient mice increased in proportion to the duration of infection of the donor mice.
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Thus, the onset of immune protection in acute experimental Chagas' disease seems to occur
between six and nine days post-infection. This time span corresponds with the first intracellular
cycle as described by Dvorak and Hyde in 1973. They observed that intracellular proliferation
and subsequent escape of trypomastigotes takes six and one-half days and results in
approximately 512 parasites per invaded host cell. " If the sum of these observations can be
applied to the event leading to the development of immunity in vivo, then one might assume that
the first extensive interaction of the host's immune system with the parasite and its elaborate
products, if any, would not occur at the time of infection, but rather at the time of the release of
parasites following the first intracellular cycle" (Kuhn and Durum, 1975).
The humoral branch of the immune response has been shown to be enhanced in mice
maintained at 36°C as indicated by increased levels of anti T. cruzi antibodies late in infection
(Dimock et al., 1991; Dimock et al., 1992). Other research that supports increased antibody
production at elevated environmental temperatures has been reported by Culbertson and
Kolodny, 1938; Kolodny, 1940; Robertson et al., 1973. The positive effects of antibody coupled
with complement was reported by Budzko et al., 1975.
The positive effects of T cell-mediated processes on immunity against T. cruzi also have been
reported. Ming, 1994 and Guo, 1994 demonstrated that the depletion of CD8 or CD4 T cells in
vivo by the use of monoclonal antibodies resulted in an abrogation of the protective effects of
elevated temperature during acute Chagas' disease. Trischmann and Bloom (1980) reported that
when whole spleen cells from mice previously immunized against T. cruzi, with noninfective
epimastigote forms, were injected into an infected recipient group all mice given spleen cells
prior to eight days post-infection died and all mice receiving spleen cells past eight days post
infection survived.
Nogueira et al. (1981) were able to reproduce these results by injecting naive recipients with
whole spleen cells from mice that had been given a sublethal infection of T. cruzi. The whole
spleen cells also were tested in vitro for the presence of macrophage activating factors. Such
factors were successfully isolated from whole spleen cells. B cell depleted spleen cell
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populations were found to be as effective as whole spleen cells in both the ability to confer in
vivo protection in passive transfer experiments and to generate in vitro macrophage activating
factor(s). This phase of the experiment was based upon earlier studies demonstrating that
macrophages became trypanocidal during the course of an infection with T. cruzi or by exposure
to factor(s) derived from antigen or mitogen stimulated lymphocytes (Reviewed in Nogueira et
al., 1981).
A very important background study for the experiment presented in this thesis was performed
by Rowland and Ritter in 1984. In this work, they immunized mice with a less virulent strain of
T. cruzi two weeks prior to challenging the mice with a lethal dose of a virulent strain of T. cruzi.
All mice survived the otherwise lethal infection. When the immune system was experimentally
separated into adoptive and passive components the results were very similar to the results
obtained in the present study. While whole spleen cells from the immunized mice that had
survived challenge with the lethal forms of T. cruzi were found to be able to adoptively transfer
immune protection to naive recipients, no protection was imparted by either spleen cells from the
control mice or spleen cells from mice that had only received the vaccine but had not survived a
lethal challenge. Passive transfer conferred a short term protection that was evident at day 21
post infection by lower parasitemias than the controls. However, by day 28 the status of
recipient mice was no different than for the controls.

Murine model
The murine model has become the standard for studying experimental Chagas' disease. It is
important to remember when looking at various works ,with varying results, that inbred strains
of mice have been found to differ greatly in their natural resistance to T. cruzi (Reviewed in
Nogueira et al., 1981). The C3HeB/FeJ mice used in the present study have been accepted as the
strain best exemplifying susceptibility to T. cruzi (Rowland and Ritter, 1984). The age
(Culbertson and Kessler, 1942) and sex (Hauschka, 1947) of mice also influences the course of
T. cruzi infection (Trischmann et al., 1978). When C3HeB/FeJ mice are infected with T cruzi,
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they develop a significant immunosuppression that involves both nonspecific (humoral and cellmediated) and parasite-specific responses (Cunningham and Kuhn, 1980; Kuhn, 1981; Tarleton
and Kuhn, 1985).

Goals of the present study
The goals of the present study were 1) to confirm that maintenance of lethally infected
C3HeB/FeJ mice at an elevated environmental temperature of 36°C significantly lessens the
course of infection with T. cruzi, 2) to determine if this increased resistance could be transferred
to naive recipient mice held at 21°C, and 3) to determine if the immune system enhancement by
an ambient temperature of 36°C could be attributed to the components of humoral immunity by
the transfer of sera or to the components of cellular immunity via transfer of whole spleen cells.

Chapter 2
Materials and Methods

Mice
In Phase 1 of the study - 24 female C3HeB/FeJ mice obtained from the Jackson Laboratory
(Bar Harbor, Maine) were utilized. All mice were acclimated at room temperature (21°C) for
three weeks prior to use. They were eight weeks old at the time of intraperitoneal (i.p.) injection
with 1000 blood-form trypomastigotes (BFTs).

In Phase 2 of the study - 20 C3HeB/FeJ mice (17 female and 3 male) were used from a preexisting breeding colony maintained in the Department of Biology of Western Kentucky
University. These mice required no acclimation time and were infected i.p. with 1000 BFTs at
eight weeks of age.

Twenty female C3HeB/FeJ mice obtained from the Jackson Laboratory were utilized in Phase
3 of the study. All mice were acclimated at room temperature (21°C) for greater than three
weeks prior to use. They were eleven weeks old at the time of i.p. infection with 1000 BFTs.

Parasites
Mice were infected with the Brazil strain of T. cruzi which is maintained in this laboratory as
a stock infection in C3HeB/FeJ mice. Parasites were harvested via a cardiac puncture performed
immediately post cervical dislocation of a donor mouse. One ml of blood was recovered and
placed in ten mis of sterile Dulbecco's phosphate buffered saline (DPBS; Gibco Laboratories,
Grand Island, New York). The suspension was centrifuged at 1800g for 15 minutes in order to

26

33

wash the parasites free of any donor antibodies and other serum components. The supernatant
was decanted and discarded. Then, 15 ml of fresh sterile DPBS was added and gentle vortexing
was applied in order to resuspend the solution. The BFTs were counted using a hemacytometer
and the parasite suspension was diluted in sterile DPBS to a final concentration of 5 x 103
parasites/ml of blood.
Following infection, mice were either maintained in the animal facility in the Department of
Biology at Western Kentucky University at room temperature (21°C) or were placed in an
environmental chamber which was held at a temperature of 36°C. Both conditions were kept
under a 12 hour light/12 hour dark photoperiodic cycle. Food and water were provided ad
libitum. All mice were maintained and used in accordance with local IACUC guidelines.

Experimental design
Phase 1- The mice in this phase were used as donors for the passive and adoptive transfer
experiments. Six mice were infected and immediately placed in the room temperature
environment (RTI). Six mice were infected and immediately placed in the elevated temperature
environment (ETI). There also were accompanying noninfected control groups (RTNI and
ETNI) at each temperature. Both room temperature groups were euthanised at day 35 post
infection. Day 35 was chosen because C3HeB/FeJ mice have been shown to succumb to a lethal
infection of T. cruzi between day 35 and 45. One mouse died prior to this date and the others
were showing obvious signs of deterioration and oncoming expiration at this time. Mice
maintained at elevated temperature were euthanised on day 98 of infection, after parasitemia
levels had dropped to zero.

Phase 2- The mice in this phase were naive recipients of either whole spleen cells or sera
from the room temperature infected and noninfected groups of Phase 1. Four groups of five
mice each received the following treatments:
Group 1 = room temperature infected whole spleen cells (RTI spleen).
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Group 2 = room temperature infected sera (RTI sera)
Group 3 = room temperature noninfected whole spleen cells (RTNI spleen)
Group 4 = room temperature noninfected sera (RTNI sera)
All recipient mice were maintained continuously at room temperature.

Phase 3 - The mice in this phase were naive recipients of either whole spleen cells or sera
from the elevated temperature infected and noninfected groups of Phase 1. Four groups of five
mice each received the following treatments:
Group 5 = elevated temperature infected whole spleen cells (ETI spleen).
Group 6 = elevated temperature infected sera (ETI sera)
Group 7 = elevated temperature noninfected whole spleen cells (ETNI spleen)
Group 8 = elevated temperature noninfected sera (ETNI sera)
All recipient mice were maintained continuously at room temperature.

Serum preparation
Serum was chosen for passive transfer experiments because it contains the highest
concentration of immunoglobulin. Donor blood was harvested by cardiac puncture and allowed
to clot. It was then centrifuged at approximately 1500 rpm for 10 minutes. Sera were removed
and divided into 0.6 ml aliquots which were placed into microcentrifuge tubes and stored at -70°
C until use. All sera used in this experiment had only been subjected to one freeze-thaw cycle.
Each mouse receiving sera was given an i.p. injection of 0.1 ml 24 hours prior to infection and
every subsequent week for a total of four weeks. Weekly injections were given due to the fact
that the shortest half life of any IgG subset is seven days (Benjamini and Leskowitz, 1989).

Source of cellular components
Spleen cells were chosen for adoptive transfer experiments due to the fact that the splenic
white pulp is rich in both T and B cells and the splenic red pulp is rich in macrophages.
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Spleens were aseptically removed immediately post mortem of the donor mice and placed into
serum-free RPMI-1640 medium. Large forceps were used to gently disrupt the splenic capsule.
The freed spleen cells, floating free in the media, were drawn into a 10 ml syringe through a 22
gauge needle and expelled slowly through a 26 gauge needle into a sterile tube. This step
released the spleen cells from the splenic matrix. The cell suspension was centrifuged at 1500
rpm for 10 minutes. The supernatant was decanted and the cells were resuspended in 0.5 ml l x
DPBS. The red blood cells were lysed via hypotonic shock by adding 4.5 ml of distilled water
and then in less than ten seconds adding 0.5 ml of lOx DPBS to restore tonicity. The suspension
was centrifuged again at 1500 rpm for 10 minutes. After this procedure, RBC "ghosts" were
mechanically removed. Spleen cells were resuspended in 5 ml of serum-free RPMI-1640 media.
The cells were then quantified using a hemacytometer. Each mouse was injected i.p. with 1 x
10^ whole spleen cells 24 hours prior to infection. This treatment was administered only once.

Parasitemias
Parasitemia levels were monitored in all infected mice beginning at day 13 post infection and
continuing every 3 to 4 days throughout the course of infection. A 4 | x l sample of blood was
taken from the tail and diluted in 96

of lx DPBS. Parasitemias were counted using a

hemacytometer and an Olympus microscope. Mice were closely monitored for morbidity and
mortality.

Statistical analysis
All statistical analyses were done using Systat (Wilkinson, 1992). For each treatment group,
peak parasitemia (highest parasitemia reached by any mouse in a given treatment group) and the
day on which the peak occurred were determined. These values were log transformed to
equalize variances among treatment groups prior to analysis of variance. Treatment groups were
tested for significant differences in the day post infection that peak parasitemia was observed per
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group, the peak number of parasites/ml of blood reached by each group, and their interaction
using MANOVA.
Probabilities for individual treatment groups were calculated using a Tukey's HSD multiple
pairwise comparison procedure. This test was employed to assess significance of comparisons
involving the ETI spleen group. Because it corrects for the large number of simultaneous tests
performed, the HSD test biases the comparisons against finding any significant difference
between ETI spleen group and the other seven treatment groups. Differences were considered
significant at the P < 0.05.

Chapter 3
Results

Effect of elevated temperature on parasitemia
Mice infected with a lethal injection of T. cruzi were placed at either 21°C or 36°C in order to
determine the effects of environmental temperature on parasitemia and course of disease. The 21
°C group demonstrated an average onset of parasitemia beginning at day 14.6 post infection (see
Table 1). BFTs showed a rapid and steady increase in number in this group until time of
euthanasia (day 35) when parasite levels were at their highest with a mean peak of >700 x 10^
parasites/ml of blood (see Fig. 1). The mice maintained at room temperature were clinically
emaciated in the latter days of infection and one succumbed prior to day 35 post infection. Mice
in the 36°C group displayed a delayed onset of parasitemia beginning at day 20 and a much
slower progression of parasitemia beginning at approximately day 35 and peaking on day 74 at
272 x 10^/ml of blood, less than half the number of parasites observed in the 21°C group (see
Fig. 1). This group began a decline in parasite numbers beginning at day 80 and progressing to
essentially undetectable levels by day 90 post infection. Clinically, five of these mice appeared
healthy throughout infection. However, one mouse within this group showed a spike in
parasitemia of 1400 x 10^ on day 74 and died on day 75 post infection. No survival results are
reported on either of these groups of mice because they were not allowed a natural course of
infection, but instead were euthanised to accommodate the design of this study. Given that 80%
of the mice held at 36°C were able to exhibit lower parasite numbers and resolve parasitemia, it
was of interest to determine if the protection imparted by elevated environmental temperature
could be adoptively or passively transferred to naive infected mice maintained at 21°C.
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Effect of passive transfer of sera on parasitemia and survival
To evaluate the contribution of antibodies and other serum components to the altered course
of infection including lower parasitemias, increased longevity, and eventual clearing of BFTs
noted in infected mice held at 36°C, pooled sera from infected and noninfected mice maintained
at 36°C, as well as, from infected and noninfected mice maintained at 21°C were transferred to
four sets of naive mice. Recipient mice were given a lethal dose of T. cruzi and held at 21°C for
the duration of the experiment. Transfer of sera from infected mice held at both temperatures
resulted in an average onset of parasitemia of 14.2 days (see Table 1). In all cases the
parasitemia levels began to increase at approximately day 20 post infection, and continued to
rise, reaching levels exceeding those of the respective controls and those seen with the 21°C
donor mice (see Table 1). All mice receiving sera died on days 35-59 post infection (see Fig. 3).

Effect of adoptive transfer of spleen cells on parasitemia and survival
Administration of whole spleen cells was utilized to determine if the enhanced immune
responsiveness seen at elevated temperatures, including lower parasitemia and increased
survival, could be adoptively transferred to infected mice held at 21°C. The groups receiving
spleen cells from both the 21°C and 36°C donor mice had an average onset in parasitemia of day
15.8 and the lowest peak parasitemia levels of all treatment groups (415 X 10^ and 14 X 10^
resp.). However, only the group receiving whole spleen cells from infected mice maintained at
elevated temperature showed significant difference in peak parasitemia levels. The mice
receiving spleen cells from the 21°C group and the noninfected controls displayed a general
trend resembling that seen for the 21°C group with rapid increases in parasitemia levels
beginning at approximately day 20 post infection and continuing to increase to similar peak
levels (see Table 1). The groups receiving noninfected whole spleen cells (ETNI whole spleen)
as well as whole spleen cells from the 21°C infected mice (RTI whole spleen) and the 21°C
noninfected mice (RTNI whole spleen) had a 100% mortality rate on day 36-55 post infection
(Fig. 2). However, those mice receiving the whole spleen cells from the mice originally
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maintained at 36°C demonstrated a very significant difference in pattern of infection. The mice
in this group displayed very low parasitemias with a mean peak of 14 x lO^/ml of blood and
rapidly cleared the BFTs by approximately day 40 of infection. These parasite levels were
considerably lower than seen in the original mice that survived infection at 36°C and served as
donors for this group.
Results of statistical analysis
Although peak day, peak parasitemia levels, and day of 100% group mortality varied among
the groups receiving sera, a Tukey's pairwise comparison test showed no significant difference at
the 0.05 level in peak parasitemia level or peak day among any of the treatment and control
groups (see Fig. 4). Among all treatment groups receiving whole spleen cells there was no
significant difference in the day peak parasitemia occurred (F 7 32 = 1.753; P = 0.136).
However, the peak parasitemia level differed significantly among groups, in particular, the ETI
spleen group parasitemia levels were significantly lower than all other treatment groups
according to the HSD criterion (F 7^ 32 = 11.764; P = < 0.001).
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TABLE 1. Summary of parasitemia and mortality data for Phase 1, 2, and 3. RTI refers to room
temperature infected. RTNI refers to room temperature noninfected. ETI refers to elevated
temperature infected. ETNI refers to elevated temperature noninfected.

Group

Onset

Mean Peak
Parasitemia

Peak day

Day of 100%
Mortality

RTI

14.6

715 x 1 0 4 a

33

*****

ETI

20

272 x 1 0 4 a

74

*****

RTI sera

13

739 x 1 0 4 a

33

47

RTNI sera

19.8

435 x 1 0 4 a

35

59

RTI spleen

15

415 x 1 0 4

a

33

55

RTNI spleen

15.6

136 x 10 4

a

33

47

ETI sera

15.4

1680 x 10 4

a

39

45

ETNI sera

13

1185 x 10 4

a

33

35

ETI spleen

16.6

ETNI spleen

13

14 x 1 0 4 b
565 x 10 4

a

a = groups demonstrating no statistically significant differences
b = group demonstrating statistically significant differences
* = groups euthanised
- = groups still alive

19 and 33
29

36

35

FIGURE 1. Effect of 21°C versus 36°C environmental temperature on parasitemia and course
of infection with T. cruzi. The mice maintained at room temperature were euthanised on day 35
of infection. The mice held at elevated temperature were euthanised on day 98 of infection.
Data are presented as the mean number of parasites per ml of blood, with six mice per group.
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FIGURE 2. The effect of adoptive or passive transfer on parasitemia levels in Phase 2. The
average parasitemias in recipients of sera or whole spleen cells from infected mice, as well as
noninfected controls maintained at 21°C are given. Recipient mice were infected with 10 3 BFTs
and held at 21°C. Data are presented as the mean number of parasites per ml of blood, with five
mice per group. RTI refers to room temperature infected. RTNI refers to room temperature
noninfected.
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FIGURE 3. The effect of adoptive or passive transfer on the survival of recipients in Phase 2.
RTI refers to room temperature infected. RTNI refers to room temperature noninfected.
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FIGURE 4. The effect of adoptive or passive transfer on parasitemia levels in Phase 3. The
average parasitemias in recipients of sera or whole spleen cells from infected mice, as well as,
noninfected controls maintained at 36°C are given. Recipient mice were infected with 1(P BFTs
and held at 21°C. Data are presented as the mean number of parasites per ml of blood, with five
mice per group. ETI refers to elevated temperature infected. ETNI refers to elevated temperature
noninfected.
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FIGURE 5. The effect of adoptive or passive transfer on the survival of recipients in Phase 3.
ETI refers to elevated temperature infected. ETNI refers to elevated temperature noninfected.
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Chapter 4
Discussion

The results of this study demonstrate that an elevated environmental temperature of 36°C can
significantly alter the course of a lethal infection with the Brazil strain of T. cruzi in highly
susceptible C3HeB/FeJ mice by delaying onset of parasitemia, decreasing peak parasitemia
levels, prolonging the day peak levels are reached, clearing of BFTs, and increasing longevity.
This finding has been documented by several other investigators (Anderson and Kuhn, 1989;
Dimock et al., 1991; Guo, 1994; Ming, 1994; Gao, 1995). Maintenance of T. cruzi-infected

mice

at 36°C has been shown to not only increase survival rate and decrease parasitemia levels but
also to significantly enhance both parasite-specific and nonspecific immune responses (Anderson
and Kuhn, 1989; Gao, 1995). However, the immune mechanisms responsible for this enhanced
immune responsiveness have not been clearly defined.
The results of the present study demonstrate that the protection observed at elevated
temperature can be transferred to naive mice by adoptive transfer of whole spleen cells from
mice that have survived infection at 36°C. The success of adoptive transfer indicates that cellmediated immunity is responsible for the enhanced protection. The mice receiving this treatment
displayed significantly lower parasitemias, rapidly cleared circulating BFTs, and had a 100%
survival rate in contrast to all other treatment groups that were not statistically different from
their controls and had a 100% mortality rate.
In contrast, the results of this study provide no evidence for immune protection imparted
passively through sera as demonstrated by a course of infection similar to the controls, the
highest parasitemias, and a 100% mortality. Studies performed by Dimock et al., 1991, also
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suggest that antibodies do not play a major role in the protection observed at elevated
temperatures. These antibodies do not play a major role in the protection observed at elevated
temperatures. These investigators reported no correlation between antibody levels and
parasitemias or survival. Using ELISA and immunoblot analysis the authors found that anti-75
cruzi antibodies were initially low in mice maintained at 36°C, but by day 40 post infection the
parasite specific antibody levels were similar to those seen in mice held at room temperature.
Furthermore, antibody levels continued to steadily increase throughout infection, peaking at day
91. These results indicate that antibody levels peak far too late to stop the acute stage of
infection but may play a role in late infection. The data from the present experiment support this
conclusion. There were no significant differences observed in peak parasitemia levels or peak
day between the mice given sera from infected mice and control mice indicating no additional
protection by antibodies. Passive transfer was not successful and a 100% mortality rate
occurred. Guhl et al., 1979, postulated that antibodies accounted for the beneficial effects seen at
elevated temperature based upon the successful transfer of immunity to naive recipients using
hyper-immune sera. Varying results may be due to usage of various strains of T. cruzi or mice.
Also, these investigators used daily injections of a large quantity of sera (0.2 ml) which may
have contributed to the outcome.
The present results strongly indicate that cellular immune responses play a significant role in
controlling infection in the early course of disease and that it is this branch of immunity that is
enhanced at elevated temperatures. The enhanced protection observed at elevated temperature
can be imparted to naive mice by the adoptive transfer of whole spleen cells from mice that have
survived infection at 36°C. The recipients of whole spleen cells displayed even lower
parasitemias and more rapid clearing of parasites than the original donors. Several other
investigators also have attributed the immune protection seen at elevated environmental
temperatures to the components of cell-mediated immunity. Direct plaque-forming cell
responses to sheep red blood cells, as well as the parasite specific responses of T helper cells
have been shown to be significantly enhanced in T. cruzi infected mice held at 36°C (Anderson
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and Kuhn, 1989). The in vivo depletion of the T helper cell subset was shown to advance the
onset of parasitemia approximately four days in mice maintained at either environmental
temperature (Guo, 1994). In addition, all mice maintained at elevated temperature and depleted
of T helper cells exhibited 100% mortality. However, this same study demonstrated that
maintenance of mice at elevated temperatures still exerted some protective effects even after the
depletion of C D 4 + cells. Guo suggested that this effect may be due to either partial cell recovery
or to other unknown components of the immune system. Such " other " components may include
cytokines such as IL-1 which has been shown to enhance T cell responses in vitro at elevated
temperatures (Duff and Durum, 1983) or IL-2 which has been shown to have depressed levels in
murine spleen cells during the course of natural infection with T. cruzi (Harel-Bellan et al., 1983;
Tarleton and Kuhn, 1984; Tarleton 1988). IL-2 is critically important in the regulation of a wide
variety of immune responses (Mosmann et al., 1991), and elevated temperature has been shown
to be a powerful promoter of IL-2 transcription and synthesis (Gern et al., 1991). Several
investigators have declared both C D 4 + and CD8 + T cells to be involved in the immune response
to this parasite in several species of murine models (Trischmann, 1983; Tarleton, 1990; Tarleton
et al., 1992). Ming (1994) demonstrated that the depletion of CD8 + cells can reverse the positive
effects noted with elevated temperature. Further studies will be required to determine if C D 4 + T
cells or C D 8 + T cells (or both) are responsible for the success of adoptive transfer. In addition,
despite the positive evidence for T cell activity in this phenomenon, the role of macrophages
cannot be excluded due to the use of whole spleen cells in this study.
The results of the present study provide strong evidence that cellular immunity is enhanced by
maintenance of infected mice at an elevated environmental temperature. The adoptive transfer of
whole spleen cells from mice that have survived a lethal inoculation of T. cruzi by maintenance
at 36°C to naive, lethally infected recipients maintained at 21°C imparted immunity that allowed
for very low parasitemias, quick clearing of BFTs from the bloodstream, and a 100% survival
rate. In contrast, passive transfer of sera resulted in no additional protection over that seen with
the control mice and even allowed for higher parasitemias than those seen in the controls.
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In this study, the goal was to attempt to identify which branch of the immune system becomes
enhanced when mice are maintained at 36°C and are given a lethal infection of the Brazil strain
of T. cruzi. Previous studies have indicated that the enhanced immunity is an immunological
phenomenon but have raised questions regarding which aspects of the immune system are
responsible for the observed protection. The data presented in this thesis unequivocally
demonstrate that the protection is due to enhanced cellular immunity with little to no early
contribution by antibodies.

Literature Cited

Alonso, K., P. Pontiggia, C. Nardi, A. Saboto, and F. Cuppone Curto. 1992. Systemic
hyperthermia in the treatment of HIV-related Kaposi's sarcoma. Biomedical and
Pharmacotherapy 45: 121 -124.

Amrein, Y.U. 1967. Research note: Effects of environmental temperature on

Trypanosoma

cruzi infection in mice. Journal of Parasitology 53: 1160.

Anderson, K.J. 1990. Effects of elevated environmental temperature on the course of
experimental Chagas' disease. Ph.D. thesis, Wake Forest University, Winston-Salem, North
Carolina, 129 p.

Anderson, K.J., and R.E.Kuhn. 1989. Elevated environmental temperature enhances immunity
in experimental Chagas'disease. Infection and Immunity 57: 13-17.

Anderson, W.I., W.M. Reed, and J.K. Johnson. 1976. Effects of high environmental
temperatures on cecal coccidiosis. Poultry Science 55: 1429-1435.

Arif, A. A. 1996. Antibody response to heat shock proteins of Trypanosoma cruzi and
histopathology in mice infected and maintained at elevated environmental temperature. M. S.
Thesis. Department of Biology, Western Kentucky University, Bowling Green, Kentucky, 52 p.

44

45

Atkins, E. 1984. Fever: the old and the new. Journal of Infectious Disease 149:339-348.

Benjamini, E. and Leskowitz, S. 1988. Immunology a Short Course. Alan R. Liss., New York,
New York, 390 p.

Bernard, C., T.A. Robertson, and J.M. Papadimtriou. 1994. Elevated temperature accelerates
and amplifies the induction of nitric oxide synthesis in rat macrophages. European Journal of
Pharmacology 270: 115-118.

Bertelli, M.S.M., R.R. Golgher, and Z. Brener. 1977. Intraspecific variation in Trypanosoma
cruzi: effect of temperature on the intracellular differentiation in tissue culture. Journal of
Parasitology 63: 434-437.

Bogitsh, B.J., and C. Cheng. 1990. American trypanosomiasis. In Human Parasitology.
Saunders College Publishing, New York, New York, p. 105-109.

Brener, Z. 1992. Trypanosoma cruzi: taxonomy, morphology and life cycle; historical aspects.
In Chagas' Disease - American Trypanosomiasis: Its Impact on Transfusion and Clinical
Medicine, S. Wendel, Z. Brener, M.E. Camargo, and A. Rassi (eds.) ISBT Brazil, Sao Paulo,
Brazil.

Budzko, D.B., M.C. Pizzimenti, F. Kierszenbaum. 1975. Effects of complement depletion in
experimental Chagas' disease: Immune lysis of virulent blood forms of Trypanosoma

cruzi.

Infection and Immunity 11:86-91.

Burleigh, B.A., and N.W. Andrews. 1995. The mechanisms of Trypanosoma cruzi invasion of
mammalian cells. Annual Review of Microbiology 49: 175-202.

46

Chagas, C. 1909. Nova tripanozamiaze humana: estudios sobre a morfolojia e o ciclo evolutivo
do Schizotrypanum

cruzi n. gen., d. sp., agente etiolojico de nova entidade morbida do homem.

Mem. Inst. Oswaldo Cruz 1: 159-218.

Choromanski, L., and R.E. Kuhn. 1985. Interleukin 2 enhances specific and nonspecific immune
responses in experimental Chagas' disease. Infection and Immunity 50: 354-357.

Choromanski, L., and R.E. Kuhn. 1987. Use of parasite antigens and interleukin-2 to enhance
suppressed immune responses during Trypanosoma cruzi infection in mice. Infection and
Immunity 55: 403-408.

Culbertson, J.T., and W.R. Kessler. 1942. Age resistance of mice to Trypanosoma

cruzi.

Journal of Parasitology 28: 155-158.

Culbertson, J.T., and M.H. Kolodny. 1938. Acquired immunity in rats against Trypanosoma
cruzi. Journal of Parasitology 24: 83-90.

Cunningham, D.S., and R.E. Kuhn. 1980. Trypanosoma crwz/'-induced suppression of the
primary immune response in murine cell cultures to T-cell-dependent and -independent antigens.
Journal of Parasitology

66:16-27.

Dimock, K.A., C.D. Davis, and R.E. Kuhn. 1991. Effect of elevated environmental temperature
on the antibody response of mice to Trypanosoma cruzi during the acute phase of infection.
Infection and Immunity 59: 4377-4382.

47

Dimock, K.A., C.D. Davis, and R.E. Kuhn, 1992. Changes in humoral responses to
Trypanosoma cruzi during the course of infection in mice held at elevated temperature.

Journal

of Parasitology 78: 687-696.

Duff, G.W., and S.K. Durum. 1983. The pyrogenic and mitogenic actions of interleukin-1 are
related. Nature 304:449-451.

Dvorak, J. A., and T.P. Hyde. 1973. Trypanosoma cruzi: Interaction with vertebrate cells in vitro.
I. Individual interactions at the cellular and subcellular level. Experimental Parasitology 34:
268-283.

Dvorak, J.A., and C.M. Poore. 1974. Trypanosoma cruzi: interaction with vertebrate cells in
vitro. Experimental Parasitology 36: 150-157.

Engman, D.M., E.A. Dragon, and J.E. Donelson. 1990. Human humoral immunity to hsp70
during Trypanosoma cruzi infection. Journal of Immunolgy 144: 3987-3991.

Fackelmann, K. 1997. Paleopathological puzzles: Researchers unearth ancient medical secrets.
Science News 152: 136-137.

Gao, L. 1995. Antibody response to Trypanosoma cruzi during the course of infection in mice
held at elevated environmental temperature. M. S. Thesis. Department of Biology, Western
Kentucky University, Bowling Green, Kentucky, 40 p.

Gern, J.E., J.R. Jayman, L.I. Goldberg, P.A. Murphy, and H.M. Lederman. 1991. Temperature
is a powerful promoter of interleukin 2 transcription. Cytokine 3:3 89-397.

48

Green, S.J., C.A. Nacy, and M.S. Meltzer. 1991. Cytokine-induced synthesis of nitrogen oxides
in macrophages: A protective host response to Leishmania and other intracellular pathogens.
Journal of Leukocyte Biology 50: 93-103.

Guhl, F., C.J. Marinkelle, N. de Sanchez, and M. Grogl. 1979. Estudios sobre la transferencia
de inmunidad humoral contra Trypanosoma cruzi inducida por calor en ratones. Revista do
Instituto de Medicina. Tropical de Sao Paulo 21: 166-171.

Guo, Q. 1994. The role of CD4 + T cells in the immune response to Trypanosoma cruzi in mice
held at elevated temperature. M. S. Thesis. Department of Biology, Western Kentucky
University, Bowling Green, Kentucky, 55 p.

Hanson, D.F. 1993. Fever and the immune response: the effects of physiologic temperatures on
primary murine splenic T-cell responses in vitro. Journal of Immunology 151: 436-448.

Harei-Bellan, A., M. Joskowicz, D. Fradelizi, and H. Eisen. 1983. Modification of T-cell
proliferation and interleukin 2 production in mice infected with Trypanosoma cruzi. Proceedings
of the National Academy of Sciences 80: 3466-3469.

Hauschka, T.S. 1947. Sex of host as a factor in Chagas' disease. Journal of Parasitology 33:
399-404.

Healy, A.M., E. Mariethoz, L. Pizurki, and B.S. Polla. 1992. Heat shock proteins in cellular
defense mechanisms and immunity. Annals of the New York Academy of Science 663: 319330.

49

Hedstrom, R.J., V. Culpepper, N. Agabian, and G. Newport. 1988. Schistosome heat-shock
proteins are immunologically distinct host like antigens. Molecular and Biochemical
Parasitology 29: 275-282.

Hotchkiss, R., I. Nunnally, S. Lindquist, J. Taulein, G. Perdrizet, and I. Karl. 1993.
Hyperthermia protects mice against the lethal effects of endotoxin. American Journal of
Physiology 265: R1447-R1457.

Jaattela, M., K. Saksela and E. Saksela. 1989. Heat shock proteins WEHI-164 target cells from
the cytolysis by tumor necrosis factors a and p. European Journal of Immunology 19: 14131417.

Jampel, H.D., G.W. Duff, R.K. Gershon, E. Atkins, and S.K. Durum. 1983. Fever and
immunoregulation. III. Hyperthermia augments the primary in vitro humoral immune response.
Journal of Experimental Medicine 157: 1229-1238.

Janeway, C.A., and P. Travers. 1996. Immunobiology: The Immune System in Health and
Disease, 2nd Edition. M. Robertson, E. Lawrence, E. Hunt, and E. Dorey (eds.). Garland
Publishing Inc., New York, New York, p. 1-32.

Kirchhoff, L.Y. 1993. American trypanosomiasis (Chagas' disease) - A tropical disease now in
the United States. The New England Journal of Medicine 329: 639-644.

Kluger, M.J. 1991. Fever: Role of pryogens and cryogens. American Physiology Society
Physiological Reviews 71:93-127.

50

Kluger, M.J., and L.K. Vaughn. 1978. Fever and survival in rabbits infected with Pasteurella
multocida.

Journal of Physiology

282:234-251.

Kolodny, M.H. 1939. Seasonal variations in the intensity of experimental infection with
Trypanosoma cruzi in young rats. American Journal of Hygiene 29: 131-133.

Kolodny, M.H. 1940. The effects of environmental temperature upon experimental
trypanosomiasis {T. cruzi) of rats. American Journal of Hygiene 32:21-23.

Kuhn, R.E. 1981. Immunology of Trypanosoma cruzi infections. In Parasitic Diseases: The
Immunology. Marcel Dekker, Inc., New York, New York, p.137-166.

Kuhn, R.E., and S.K. Durum. 1975. The onset of immune protection in acute experimental
Chagas' disease in C3H(HE) mice. International Journal of Parasitology 5: 241-244.

Logan, W.D., and K. Alonso. 1991. Total body hyperthermia in the treatment of Kaposi's
sarcoma in an HIV positive patient. Medical Oncology and Tumor Pharmacotherapy 8: 45-47.

Mackowiak, P. A. 1981. Direct effects of hyperthermia on pathogenic microorganisms:
teleologic implications with regard to fever. In Reviews of Infectious Diseases Vol.3, No.3. The
University of Chicago, Illinois, p. 508-520.

Margulis, B.A., S. Sandler, D.L. Eizirik, N. Welsh, and M. Welsh. 1991. Liposomal delivery of
purified heat shock protein hsp70 into rat pancreatic islets as protection against interleukin 1 (3induced impaired P-cell function. Diabetes 40: 1418-1422.

51

Marinkelle, C.J., and E. Rodriguez. 1968. The influence of environmental temperature on the
pathogenicity of Trypanosoma cruzi infection in mice. Experimental Parasitology 23: 260-263.

Mattei, D., A. Scherf, O. Bensaude, and L.P. Da Silva. 1989. A heat shock-like protein from
the human malaria parasite Plasmodium falciparum

induces autoantibodies. European Journal of

Parasitology 19: 1823-1828.

Ming, Z. 1994. The role of C D 8 + T cells in the immune response to Trypanosoma cruzi in mice
held at elevated environmental temperature. M.S. Thesis. Department of Biology, Western
Kentucky University, Bowling Green, Kentucky, 39 p.

Miyamoto, H., M. Ogawa, K. Maruta, Y. Nikaido, C. Yamamoto, H. Taniguchi, and S. Yoshida.
1995. Temperature effects on Legionella pneumophila

killing by and multiplication in

phagocytes of guinea pigs. Microbiology and Immunology 39: 647-654.

Mosmann, T.R., H. Cherwinski, M.W. Bond, M.A. Giedlin, and R.L. Coffman. 1986. Two types
of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and
secreted proteins. Journal of Immunology 136:2348-2357.

Mosmann, T.R., J.H. Schumaker, N.F. Street, R. Budd, A.O'Garra, M.W. Bond, K.W.M. Moore,
A. Sher, and D.F. Fiorentino. 1991. Diversity of cytokine synthesis and function of mouse
C D 4 + T cells. Immunology Reviews 123:209-312.

Nabors, G.S., and R.L. Tarleton. 1991. Differential control of interferon-gamma and IL-2
production during Trypanosoma cruzi infection. Journal of Immunology 146: 3591-3598.

52

Neva, F.A., M.F. Malone, and B.R. Myers. 1961. Factors influencing the intracellular growth of
Trypanosoma cruzi. American Journal of Tropical Medicine and Hygiene 10: 140-149.

Newport, G., L. Culpepper, andN. Agabian. 1988. Parasite heat-shock proteins. Parasitology
Today 4: 306-312.

Nogueira, N. and Z. Cohn. 1976. Trypanosoma cruzi: mechanism of entry and intracellular fate
in mammalian cells. Journal of Experimental Medicine 143:1402-1420.

Nogueira, N., J. Ellis, S. Chaplan, and Z. Cohn. 1981. Trypanosoma cruzi: In vivo and in vitro
correlation between T-cell activation and susceptibility in inbred strains of mice. Experimental
Parasitology 51: 325-334.

O'Reilly, T., and O. Zak. 1992. Elevated body temperature restricts growth of Haemophilus
influenzae type b during experimental meningitis. Infection and Immunity 57: 3458-3465.

Otieno, L.H. 1972. Influence of ambient temperature on the course of experimental
trypanosomiasis in mice. Annals of Tropical Medicine and Parasitology 66: 15-24.

Otieno, L.H. 1973. Effects of immunosuppressive agents on the course of Trypanosoma
(trypanazoon) brucei infections in heat-stressed mice. Transactions of the Royal Society of
Tropical Medicine and Hygiene 57: 856-868.

Overgaard, J. 1977. Effect of hyperthermia on malignant cells in vivo: a review and a
hypotheses. Cancer 39: 2637-2646.

53

Owens, S.D., and P.W. Gasper. 1995. Hyperthermic therapy for HIV. Medical Hypotheses 44:
235-242.

Reed, S.G., C.F. Nathon, D.L. Pihl, P. Roddicks, K. Shanebeck, P.J. Conlon, and K.H. Grabstein.
1987. Recombinant granulocyte/macrophage colony stimulating factor activates macrophages to
inhibit Trypanosoma cruzi and release hydrogen peroxide: comparison with interferon gamma.
Journal of Experimental Medicine 166: 1734-1746.

Ribeiro-dos-Santos, R., M.A. Rossi, J.L.Laus, J.S. Silva, W. Savino, and J. Mengel. 1992. AntiCD4 abrogates rejection and reestablishes long-term tolerance to syngeneic newborn hearts
grafted in mice chronically infected with Trypanosoma cruzi. Journal of Experimental Medicine
175: 29-39.

Roberson, E.L., W.L. Hanson, and W.L. Chapman. 1973. Trypanosoma cruzi: Effects of antithymocyte serum in mice and neonatal thymectomy in rats. Experimental Parasitology 34: 168180.

Robins, H.I., A. Mugander, J.D. Cohen. 1989. Whole-body-hyperthermia in the treatment of
neoplastic disease. Radiology Clinics of North America 27:803-830.

Rodbard, D. 1981. The role of regional body temperature in the pathogenesis of disease. New
England Journal of Medicine 305: 808-814.

Rowland, E.C., and D.M. Ritter. 1984. Corpus Christi strain induced protection to

Trypanosoma

cruzi infection in C3H(He) mice: transfer of resistance to Brazil strain challenge with
lymphocytes. Journal of Parasitology 70: 760-766.

54

Ryan, A.J., S.W. Flanagan, P.L. Moseley, and C.V. Gisolfi. 1992. Acute heat stress protects rats
against endotoxin shock. Journal of Applied Physiology 73: 1517-1522.

Scott, M.T. 1981. The nature of immunity against Trypanosoma cruzi in mice recovered from
acute infection. Parasite Immunology 3:209-218.

Steinhart, C.R., S.R. Ash, C. Gingrich, D. Sapir, G.N. Keeling, and M.B. Yatvin. 1996. Effect of
whole-body-hyperthermia on AIDs patients with Kaposi's sarcoma: A pilot study. Journal of
Aquired Immune Deficiency Syndromes and Human Retrovirology 11: 271-281.

Stine, G.J. 1992. Aquired Immune Deficiency Syndrome: Biological, Medical, Social, and
Legal Issues, 1st edition. Englewood Cliffs: Prentice Hall. 150 p.

Street, N.E., and T.R. Mosmann. 1991. Functional diversity of T lymphocytes due to secretion
of different cytokine patterns. FASEB Journal 5:171-177.

Tarleton, R.L. 1988. Trypanosoma craz/-induced suppression of IL-2 production. I. Evidence
for the presence of IL-2 producing cells. Journal of Immunology 140: 3763-2768.

Tarleton, R.L. 1990. Depletion of C D 8 + T cells increases susceptibility and reverses vaccineinduced immunity in mice infected with Trypanosoma cruzi. Journal of Immunology 144: 717724.

Tarleton, R.L. 1991. Regulation of immunity in Trypanosoma cruzi infection. Experimental
Parasitology 73: 106-109.

55

Tarleton, R.L., M.J. Grugsby, M. Postan, and L.H. Glimcher. 1996. Trypanosoma

cruzi

infection in MHC-deficient mice: further evidence for the role of both class I- and class II
restricted T cells in immune resistance and disease. International Immunology 8: 13-22.

Tarleton, R.L., B.H. Kollar, A. Latour, and M. Postan. 1992. Susceptibility of beta-2microglobulin-deficient mice to Trypanosoma cruzi infection. Nature (London) 359: 338-340.

Tarleton, R.L., and R.E. Kuhn. 1984. Restoration of in vitro immune responses of spleen cells
from mice infected with Trypanosoma cruzi by supernatants containing interleukin 2. Journal of
Immunology 133: 1570-1575.

Tarleton, R.L., and R.E. Kuhn. 1985. Measurement of parasite-specific immune responses in
vivo\ Evidence for the suppression of the antibody response to Trypanosoma cruzi. European
Journal of Immunology 15: 845-850.

Tarleton, R.L., J. Sun, L. Zhang, and M. Postan. 1994. Depletion of T cell subpopulations
results in exacerbation of myocarditis and parasitism in experimental Chagas' disease. Infection
and Immunity 62: 1820-1829.

Tarleton, R.L., L. Zhang, and M.O. Downs. 1997. "Autoimmune rejection" of neonatal heart
transplants in experimental Chagas' disease is a parasite-specific response to infected host tissue.
Proceedings of the National Academy of Science USA 94: 3932-3937.

Trejos, A., A. Godney, C. Greenblatt, and R. Cedillos. 1963. Effects of temperature on
morphologic variation of Schizotrypanum cruzi in tissue culture. Experimental Parasitology 13:
211-218.

56

Trejos, A., De M.A. Urquilla, and A.R. Paredes. 1965. Influence of environmental temperature
on the evolution of experimental Chagas' disease in mice. In Progress in Protozoology. Excerpta
Medica Foundation, Amsterdam.

Trischmann, T.M. 1983. Non-antibody-mediated control of parasitemia in acute experimental
Chagas'disease. Journal of Immunology 130:1953-1957.

Trischmann T.M., and B.R. Bloom. 1980. Trypanosoma cruzi: ability of T-cell-enriched and depleted lymphocyte populations to passively protect mice. Experimental Parasitology

49:

225-232.

Trischmann, T.M., H. Tanowitz, M. Wittner, and B. Bloom. 1978. Trypanosoma cruzv. role of
the immune reponse in the natural resistance of inbred strains of mice. Experimental
Parasitology 45: 160-168.

Van Bruggen, I. 1991. The effect of mild hyperthermia on the morphology and function of
murine resident peritoneal macrophages. Experimental Molecular Patholology 55: 119-134.

Wan, J., and G.L. Blackburn. 1992. Metabolic response to injury: physiologic or pathologic? In
Neuroimmunology of Fever, 1st edition. Oxford: Pergamon Press, p.201-211.

Weinstein, M.P., P.B. Iannini, C.W. Stratton, and T.C. Eickhoff. 1978. Spontaneous bacterial
peritonitis: a review of 28 cases with emphasis on improved survival and factors influencing
prognosis. American Journal of Medicine 64: 592-598.

Welch, W.J. 1992. Mammalian stress response: cell physiology, structure/function of stress
proteins, and implications for medicine and disease. Physiology Reviews 72: 1063-1081.

57

Wendel, S., and A.L. Gonzaga. 1993. Chagas' disease and blood transfusion: a new world
problem? Vox sang 64: 1-12.

WHO Technical Report Series 811. 1991. Control of Chagas' disease. World Health
Organization, Geneva.

W.H.0,/20 Press Release. 1994. Chagas' disease in retreat in the southern part of Latin
America.
World Health Organization, Geneva.

Wilkinson, L. 1992. Systat: The system for statistics. Systat, Inc. Evanston, Illinois.

Wirth, J.J., F. Kierszenbaum, G. Sonnenfeld, and A. Zlotnik. 1985. Enhancing effects of
gamma interferon on phagocytic cell association with and killing of Trypanosoma

cruzi.

Infection and Immunity 49: 61-66.

Young, R.A. 1990. Stress proteins and immunology. Annual Review of Immunology 8:401420.

